✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Gefarnate is an investigational drug.
There have been 4 clinical trials for Gefarnate. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Stomach Ulcer, Duodenal Ulcer, and Ulcer. The leading clinical trial sponsors are Takeda, Gastro-Intestinal Medical Care Research Center, and Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
Recent Clinical Trials for Gefarnate
|Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia||First Affiliated Hospital of Harbin Medical University||Phase 2/Phase 3|
|Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation||Gastro-Intestinal Medical Care Research Center||Phase 3|
|Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation||Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan||Phase 3|